
Helix B Surface Peptide (Hbsp)
MISSION CRITICAL: For in vitro laboratory research only. Not for human or veterinary use. Not evaluated by the FDA. Must be 21+.
Ara-290 is a Helix B surface peptide (HBSP) and 11-amino acid non-erythropoietic EPO analog. With the molecular formula C₅₁H₈₄N₁₆O₂₁ and a molecular weight of 1256.4 g/mol (CAS: 1208243-50-8), it structurally mimics endogenous peptides while extending its sequence.
Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-SerPublished research demonstrates Ara-290 modulates targeted signaling cascades within cell tissue models (PMID: 32345869).
In cellular environments, Ara-290 exhibits selective binding and corresponding pathway activation (PMID: 32335150).
Yao et al. (2020) investigated Ara-290's binding affinity and receptor interactions in vitro (PMID: 32345869).
Yao M, et al. (2020). Improvement of Islet Allograft Function Using Cibinetide, an Innate Repair Receptor Ligand. Transplantation.PMID: 32335150Shokrzadeh et al. (2020) investigated Ara-290's binding affinity and receptor interactions in vitro (PMID: 32335150).
Shokrzadeh M, et al. (2020). An engineered non-erythropoietic erythropoietin-derived peptide, ARA290, attenuates doxorubicin induced genotoxicity and oxidative stress. Toxicol In Vitro.